Pamela L. Kunz, MD | Authors

‘Provocative’ Data Emerge From INTRIGUE Trial ctDNA Analysis for GIST, Expert Says

January 26, 2023

Data from a ctDNA analysis of the phase 3 INTRIGUE study indicate that KIT mutational status may be associated with response to certain Tyrosine kinase inhibitors in GIST, according to an expert from the Yale Cancer Center in New Haven, Massachusetts.